Met Life Investment Management, LLC Gt Biopharma, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.68 - $15.26 $76,626 - $175,047	-11,471 Closed	0 $0
Q2 2021 May 17, 2024	BUY	$7.19 - $18.96 $82,476 - $217,490	11,471 New	11,471 $177,000
Q2 2021 Jun 21, 2023	BUY	$7.19 - $18.96 $82,476 - $217,490	11,471 New	11,471 $177,000
Q2 2021 Mar 22, 2023	BUY	$7.19 - $18.96 $82,476 - $217,490	11,471 New	11,471 $177,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $18.96 $82,476 - $217,490	11,471 New	11,471 $178,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.